211-astatine-MX35 F(ab')2

N/A

Report date: 2025/10/20 14:43:37

Base Information

Drug Name211-astatine-MX35 F(ab')2
Drug Alias Name211At-MX35 F(ab')2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Astatine > 211At +[4] 
Mechanisms of ActionSodium-dependent phosphate transport protein 2B inhibitors
TargetsSodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer CenterVästra Götaland Region
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVästra Götaland Region
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A